Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-009249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | 2022-02-10 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $237.74 | -1,230 | 58.0K | -2% | -$292.4K | |
| M | 2022-02-14 | 2022-02-11 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $235.09 | -290 | 57.7K | -0.5% | -$68.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | F | D | 1,230 | $237.74 | 58,027 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-11 | S | D | 100 | $233.92 | 57,927 | D | — | — | (F2) Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.26 to $234.24). (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-02-11 | S | D | 78 | $234.93 | 57,849 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $234.93 (range $234.28 to $235.25). |
| 4 | Common | Common Stock | 2022-02-11 | S | D | 70 | $235.87 | 57,779 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $235.87 (range $235.41 to $236.08). (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-02-11 | S | D | 42 | $236.85 | 57,737 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.84 to $236.87). |